Navigation Links
Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
Date:4/18/2012

ATLANTA, April 18, 2012 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company focused in Women's Health, recently announced the appointment of Michael Sullivan as Vice President, Sales and Marketing.  Sullivan will be responsible for all sales and marketing efforts for Avion.  Avion Pharmaceuticals recently re-launched the PRENATE FAMILY™ of prenatal vitamins, newly reformulated with QUATREFOLIC®, the fourth generation of folic acid.      

Sullivan has more than 20 years of successful prescription pharmaceutical sales and marketing experience, including "start-up" expertise.  

Mike is a graduate of Neumann University and he earned his Master's in Business Administration from Frostburg State University. 

"We are thrilled to have Mike's expertise in the Women's Healthcare category as we build our PRENATE® franchise," said Mark Pugh, CEO of Avion Pharmaceuticals.   "We are looking to Mike to assist us in expanding into other therapeutic categories and advancing our brand presence in the prescription market."

About Avion Pharmaceuticals, LLC.
Avion is a specialty pharmaceutical company that develops and markets a growing portfolio of innovative, branded pharmaceutical and dietary supplement products in the Women's Health and Dermatology areas.  Avion focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available dietary supplement products, therapeutics and late –stage development drugs to fulfill unmet medical and dietary needs.


'/>"/>
SOURCE Avion Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
2. Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™
3. Optimer Pharmaceuticals, Inc. Announces Presentation at ECCMID of Post-Hoc Subgroup Analysis of DIFICID in Adult Cancer Patients Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)
4. Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing
5. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year-End 2011 Financial Results
7. Tibet Pharmaceuticals, Inc. Announces Intent to Go Private
8. Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico
9. Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
10. Omthera Pharmaceuticals, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference
11. Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016 ... bekannt, dass sie einen entscheidenden Meilenstein durch ... Ein Aufruf zum Handeln, um Patientenresultate  bei ... trägt zu Fortschritten im Verständnis der Hepatischen ... ein Bewusstsein für Hepatische Enzephalopathie in der ...
(Date:5/2/2016)... , May 2, 2016 Leading Economies with Fastest ... 10.2 Côte d,Ivoire 8.6 Uzbekistan 8 Ireland 7.8 India 7.3, , ... BRICS nations , which comprises of Brazil , ... and South Africa , registered the fastest GDP growth ... in China , recession in Brazil ...
(Date:5/2/2016)... 2016  While nearly three-quarters of Americans (71%) are ... their health, only about half report taking any steps ... of a new survey announced today by Hologic (Nasdaq: ... National Osteoporosis Month, Hologic is raising awareness of this ... million Americans. Osteoporosis is a disease that ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... ... Rider's research and development of DRACO broad-spectrum antiviral therapeutics. DRACOs have proven effective ... starts on May 3, 2016 at http://igg.me/at/EndTheVirus and runs for 60 ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... and operators of commercial real estate proudly announced that its service-based charitable program, ... Team members portfolio-wide will continue Olshan Properties’ annual philanthropic tradition in 2016 ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nike Rugby Camp's success is ... San Diego. Willis, founder of Elite Rugby Camps and current Nike Camp director, has ... year since 2009. , “I’m excited for our eighth summer here in San ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... A new ... the world. The Duke Clinical Research Institute (DCRI) and analytics leader SAS will provide ... patient data collected by the Duke University Health System. , The DCRI and ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of Northeast TX ... people of their local community. The agency pledges to select a new beneficiary ... is to bring awareness to important local causes with fundraising and other support, ...
Breaking Medicine News(10 mins):